tirzepatide cause kidney stones (Zepbound) showed improved function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Changes in 24-Hour Urine Chemistry

Ramirez E, Bellon T, Tong HY, Borobia AM, de Abajo FJ, Lerma V, Moreno Hidalgo MA, Castaner JL, Cabanas R, Fiandor A, Gonzalez-Ramos J, Herranz P, Cachafeiro L, Gonzalez-Herrada C, Gonzalez O, Aramburu JA, Laosa O, Hernandez R, Carcas AJ, Frias J (2017) Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population

Key Takeaways What researchers say now about cancer risks linked to GLP-1 Why are there concerns about thyroid cancer with these drugs How studies compare different GLP-1 options like semaglutide Which patients might face higher risks and need extra monitoring Why talking to a doctor is critical before starting therapy What Are GLP-1 Medications

Support Healthy Blood Sugar Levels*

Topical GHK-Cu generally has a good safety profile when used as directed